Research Working Group      Policy Development Working Group      International Affairs Working Group

Linking Researchers and Industry

  • The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
  • The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
  • The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine.
  • The VPH institute has its origins in a European Commission endorsed research area on computer modeling and simulation and has been active for over 10 years.
  • This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market. 

Avicenna Alliance news

The European Commission published its Beating Cancer Plan

On 3 February the European Commission published its much-awaited Beating Cancer Plan. The Plan develops proposals and key initiatives for...

find out more ›

Alliance provides feedback on the creation of a European Health Data Space

On 3 February, the Avicenna Alliance has submitted its feedback to the inception impact assessment on the European Health...

find out more ›

European Commission publishes evaluation on Directive on patients' rights in cross-border healthcare

On 15 January, the European Commission published an evaluation and fitness check roadmap on the...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up